Procter & Gamble Health

5,503.35
+187.60
(3.53%)
Market Cap
9,135.20 Cr
EPS
121.00
PE Ratio
37.10
Dividend Yield
4.74 %
Industry
Healthcare
52 Week High
5,850.00
52 Week Low
4,636.55
PB Ratio
14.92
Debt to Equity
0.02
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,784.50 4,28,161.30 36.29 49,887.20 12.06 9,648 13.77 66.31
5,797.35 1,53,901.40 74.44 8,184.00 0.89 1,600 64.53 54.14
1,523.85 1,23,068.30 24.66 26,520.70 14.17 4,155 47.38 64.72
3,223.10 1,09,084.30 58.60 10,785.70 11.59 1,656 13.54 61.48
1,200.15 1,00,141.80 18.63 28,905.40 12.36 5,578 1.69 59.70
2,415.05 99,637.00 48.83 10,615.60 19.57 1,942 -16.38 57.94
2,114.70 96,472.10 33.67 20,141.50 19.94 1,936 38.82 62.32
918.60 92,432.70 20.38 19,831.50 13.82 3,831 29.92 52.97
1,200.35 69,716.50 19.77 29,559.20 17.55 3,169 -10.04 63.52
30,292.10 64,368.60 48.19 6,097.20 10.80 1,201 16.01 54.89
Growth Rate
Revenue Growth
-6.50 %
Net Income Growth
-12.42 %
Cash Flow Change
-3.28 %
ROE
22.19 %
ROCE
20.53 %
EBITDA Margin (Avg.)
0.25 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2020
2021
2022
2023
2024
TTM
Revenue
963
1,017
722
873
1,425
1,027
1,128
1,248
1,167
1,171
Expenses
856
877
621
701
1,041
763
847
905
845
827
EBITDA
107
140
101
173
384
264
281
343
322
345
Operating Profit %
9 %
12 %
11 %
17 %
23 %
24 %
24 %
26 %
27 %
28 %
Depreciation
23
25
19
21
30
30
27
28
27
25
Interest
0
0
0
0
0
1
0
1
1
1
Profit Before Tax
83
115
99
158
355
233
253
314
273
319
Tax
30
36
38
56
101
57
61
85
72
86
Net Profit
54
79
61
102
254
177
193
230
201
237
EPS in ₹
32.30
47.70
56.60
505.27
153.00
107.00
116.00
138.00
121.00
141.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2020
2021
2022
2023
2024
Total Assets
784
879
991
1,760
1,176
986
888
1,101
794
Fixed Assets
132
111
115
104
101
104
112
144
129
Current Assets
572
636
752
1,534
954
727
608
796
524
Capital Work in Progress
7
30
9
17
22
39
41
33
6
Investments
42
28
70
0
0
0
0
0
0
Other Assets
603
711
797
1,639
1,053
843
736
925
660
Total Liabilities
784
879
991
1,760
1,176
986
888
1,101
794
Current Liabilities
165
186
225
193
227
239
232
304
219
Non Current Liabilities
27
29
33
27
42
44
40
46
37
Total Equity
592
664
733
1,540
906
704
617
751
538
Reserve & Surplus
575
647
717
1,524
890
687
600
734
522
Share Capital
17
17
17
17
17
17
17
17
17

Cash Flow

Cash Flow
2015
2016
2017
2018
2020
2021
2022
2023
2024
Net Cash Flow
4
17
-16
1,109
-483
-172
-145
116
-197
Investing Activities
-68
-75
-48
1,270
165
-32
-26
-22
-7
Operating Activities
84
107
54
-130
235
247
170
236
228
Financing Activities
-12
-15
-22
-30
-883
-387
-289
-99
-418

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
51.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
7.59 %
6.24 %
6.40 %
6.61 %
7.02 %
DIIs
11.48 %
11.81 %
8.37 %
8.53 %
7.90 %
8.07 %
12.62 %
12.43 %
12.31 %
12.30 %
12.13 %
12.67 %
13.73 %
14.55 %
14.84 %
14.71 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.58 %
24.49 %
24.80 %
24.55 %
24.81 %
25.09 %
24.46 %
24.33 %
24.09 %
23.64 %
23.43 %
22.91 %
22.61 %
21.82 %
21.46 %
21.34 %
Others
12.13 %
11.88 %
15.01 %
15.10 %
15.47 %
15.02 %
11.11 %
11.43 %
11.78 %
12.25 %
12.62 %
5.02 %
5.60 %
5.41 %
5.28 %
5.12 %
No of Share Holders
0
53,075
58,818
63,525
65,537
66,289
65,729
65,148
61,030
58,856
57,919
56,730
56,778
55,923
54,792
53,736

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Mar 10, 2025
Integrated Filing (Financial)
Feb 18, 2025
Communication With Respect To Tds On Dividend Income Declared By The Company
Feb 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 12, 2025
Appointment Of Chairperson Of The Board
Feb 12, 2025
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 12, 2025
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 12, 2025
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 12, 2025
Corporate Action-Board approves Dividend
Feb 12, 2025
Unaudited Financial Results
Feb 12, 2025
Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25
Feb 12, 2025
Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25
Feb 12, 2025
Update on board meeting
Jan 31, 2025
Intimation Regarding Change Of The Financial Year Of The Company
Jan 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 09, 2025
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On February 12 2025
Dec 27, 2024
Closure of Trading Window
Dec 27, 2024
Change In Senior Management Personnel Of The Company
Dec 06, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGM
Dec 06, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Dec 06, 2024
Proceedings Of The 57Th Annual General Meeting Of Shareholders Held On December 5, 2024
Dec 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 21, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 20, 2024
Reg. 34 (1) Annual Report.
Nov 13, 2024
Business Responsibility and Sustainability Reporting (BRSR)
Nov 13, 2024
Annual Report And Notice Calling The 57Th Annual General Meeting Of The Company For The Financial Year Ended June 30, 2024
Nov 13, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 04, 2024
For The Quarter Ended September 30,2024
Nov 04, 2024
Board Meeting Outcome for Unaudited Financial Results
Nov 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 16, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 14, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 09, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 09, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 02, 2024
Closure of Trading Window
Sep 27, 2024
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 4, 2024
Sep 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 24, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 12, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 10, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 07, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Sep 04, 2024
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited ('The Company')
Aug 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 29, 2024
Compliances-Reg.24(A)-Annual Secretarial Compliance
Aug 29, 2024

Technical Indicators

RSI(14)
Neutral
62.16
ATR(14)
Volatile
156.01
STOCH(9,6)
Neutral
58.22
STOCH RSI(14)
Overbought
93.80
MACD(12,26)
Bullish
26.10
ADX(14)
Weak Trend
10.10
UO(9)
Bearish
57.27
ROC(12)
Uptrend And Accelerating
7.90
WillR(14)
Overbought
-15.06